Clinical Trial

Vasopressor Use Improves Macrocirculation, But What Are Its Effects on Microcirculation?

Completed
View on ClinicalTrials.gov →
Summary
To manage the treatment in the intensive care unit for patients with septic shock, central venous oxygen saturation (scvO2) is used as a macrocirculatory indicator, with a target value of 70% or higher being recommended. Tissue oxygenation (stO2) measurement can be implemented to assess the microcirculation in these patients, but a specific target value has not been established yet. The investigators believe that guiding the treatment of septic shock patients based on the measurement of microcirculation using stO2 and evaluating its correlation with scvO2 can reduce mortality. This study aims to investigate the independent impact of high-dose norepinephrine on microvascular reactivity assessed by NIRS-VOT in patients with septic shock, while also examining how these microcirculatory indices relate to the macrocirculatory marker ScvO₂.
Trial Details
NCT Number NCT07312071
Lead Sponsor Gaziosmanpasa Research and Education Hospital
Conditions Septic Shock, Sepsis, Tissue Ischemia, Hemodynamic Instability
Enrollment 30 participants
Start Date 2023-04-01
Primary Completion 2023-08-31 (estimated)
Study Completion 2023-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-31